New York State Teachers Retirement System Sells 1,632 Shares of Bruker Co. (NASDAQ:BRKR)

New York State Teachers Retirement System reduced its stake in Bruker Co. (NASDAQ:BRKR) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,815 shares of the medical research company’s stock after selling 1,632 shares during the period. New York State Teachers Retirement System’s holdings in Bruker were worth $2,158,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in BRKR. FMR LLC raised its position in shares of Bruker by 21.4% in the third quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock worth $987,981,000 after buying an additional 2,521,904 shares in the last quarter. Vaughan Nelson Investment Management L.P. increased its holdings in shares of Bruker by 140.3% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company’s stock worth $66,930,000 after buying an additional 666,617 shares during the period. Point72 DIFC Ltd increased its holdings in shares of Bruker by 4,875.9% in the third quarter. Point72 DIFC Ltd now owns 470,171 shares of the medical research company’s stock worth $32,470,000 after buying an additional 460,722 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Bruker by 1,933.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 410,234 shares of the medical research company’s stock worth $28,331,000 after buying an additional 390,057 shares during the period. Finally, State Street Corp grew its stake in shares of Bruker by 9.6% in the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock worth $250,501,000 after purchasing an additional 318,808 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

BRKR has been the topic of several recent analyst reports. UBS Group assumed coverage on Bruker in a research note on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 target price on the stock. Citigroup cut their price objective on Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Guggenheim reissued a “buy” rating on shares of Bruker in a research report on Friday, January 17th. Wells Fargo & Company dropped their price target on Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 6th. Finally, Bank of America boosted their price objective on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Bruker currently has a consensus rating of “Moderate Buy” and an average price target of $70.50.

Bruker Trading Down 4.0 %

Shares of Bruker stock opened at $50.82 on Friday. The company has a market capitalization of $7.70 billion, a P/E ratio of 66.87, a P/E/G ratio of 2.16 and a beta of 1.16. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The company has a fifty day moving average of $56.73 and a 200 day moving average of $60.03. Bruker Co. has a fifty-two week low of $48.07 and a fifty-two week high of $94.86.

Bruker (NASDAQ:BRKR) last issued its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, sell-side analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.